NPM1 and anaplastic large cell lymphoma: In ALK-positive ALCL, NPM-ALK has been shown to activate multiple signaling pathways, including PI3K/AKT, PLCγ, STAT3/STAT5 and RAS/MAPK [43,48,49,50,51,52].